Suppr超能文献

肝细胞癌组织中维生素K、免疫反应性凝血酶原、去γ-羧基凝血酶原及γ-谷氨酰羧化酶活性水平

Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.

作者信息

Yamagata H, Nakanishi T, Furukawa M, Okuda H, Obata H

机构信息

Institute of Gastroenterology, Tokyo Women's Medical College, Japan.

出版信息

J Gastroenterol Hepatol. 1995 Jan-Feb;10(1):8-13. doi: 10.1111/j.1440-1746.1995.tb01040.x.

Abstract

To clarify the mechanism of production of des-gamma-carboxy (abnormal) prothrombin (DCP) by hepatocellular carcinoma (HCC), we measured the levels of vitamin K, DCP, immunoreactive prothrombin and the activity of gamma-glutamyl carboxylase in liver tissues from HCC patients and in the medium of cultured human hepatoma cells. There was no significant difference in vitamin K (K1, MK-4) contents between HCC and non-HCC cirrhotic liver tissues. The activity of gamma-glutamyl carboxylase per unit amount of endogenous microsomal prothrombin precursor was decreased in HCC tissue compared with non-HCC liver tissue (positive plasma DCP: 335 +/- 72 vs 372 +/- 67, negative plasma DCP: 370 +/- 84 vs 393 +/- 56 nmol/min per mg prothrombin precursor, P > 0.05), although the total incorporation of 14COOH into microsomal precursor protein was higher in the former. By contrast, levels of DCP and immunoreactive prothrombin in HCC tissue were greater (P < 0.05) than those in non-HCC cirrhotic liver tissue. Furthermore, production of large amounts of immunoreactive prothrombin was observed in human hepatoma cells huH-1 and huH-2, which produced large amounts of DCP. These results suggest that there was excessive synthesis of prothrombin precursors by human HCC tissue and hepatoma cell lines huH-1 and huH-2. Thus, excessive synthesis of prothrombin precursors seems to be the main mechanism of DCP production by HCC.

摘要

为阐明肝细胞癌(HCC)产生去γ-羧基(异常)凝血酶原(DCP)的机制,我们检测了HCC患者肝组织以及培养的人肝癌细胞培养基中维生素K、DCP、免疫反应性凝血酶原水平和γ-谷氨酰羧化酶活性。HCC肝组织与非HCC肝硬化肝组织中的维生素K(K1、MK-4)含量无显著差异。与非HCC肝组织相比,HCC组织中每单位内源性微粒体凝血酶原前体的γ-谷氨酰羧化酶活性降低(血浆DCP阳性:335±72 vs 372±67,血浆DCP阴性:370±84 vs 393±56 nmol/min per mg凝血酶原前体,P>0.05),尽管前者微粒体前体蛋白中14COOH的总掺入量更高。相比之下,HCC组织中DCP和免疫反应性凝血酶原水平高于非HCC肝硬化肝组织(P<0.05)。此外,在产生大量DCP的人肝癌细胞huH-1和huH-2中观察到大量免疫反应性凝血酶原的产生。这些结果表明,人HCC组织以及肝癌细胞系huH-1和huH-2存在凝血酶原前体的过度合成。因此,凝血酶原前体的过度合成似乎是HCC产生DCP的主要机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验